Dr. Himara Davila arroyo, MD (she/her) is an Endocrinologist in Houston, TX with over 12 years of experience. What is your opinion of Dr. Himara Davila arroyo, MD? Rate this provider below so other people can make informed decision.
Over 12 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Himara Davila arroyo, MD has received over $15,582 which includes payments from the following companies:
$2,112.90 from Novo Nordisk Inc
$1,425.01 from sanofi-aventis U.S. LLC
$1,197.23 from LILLY USA, LLC
$1,144.08 from AstraZeneca Pharmaceuticals LP
$1,030.43 from INSULET CORPORATION
$1,018.58 from Tandem Diabetes Care, Inc.
$806.58 from Amgen Inc.
$619.49 from Medtronic MiniMed, Inc.
$619.39 from Corcept Therapeutics
$613.94 from Valeritas, Inc.
$544.18 from Boehringer Ingelheim Pharmaceuticals, Inc.
$446.32 from Merck Sharp & Dohme Corporation
$414.52 from Dexcom, Inc.
$358.12 from AbbVie, Inc.
$355.35 from Abbott Laboratories
$308.45 from Shire North American Group Inc
$252.99 from Janssen Pharmaceuticals, Inc
$235.46 from Pfizer Inc.
$198.01 from Radius Health, Inc.
$162.34 from Amarin Pharma Inc.
Payments received by Dr. Himara Davila arroyo, MD were from the following categories:
$14,453.08 Food and Beverage
$900.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!